LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

West Pharmaceutical Services Inc

Suletud

SektorTervishoid

327.95 -0.74

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

326.77

Max

329.25

Põhinäitajad

By Trading Economics

Sissetulek

6.7M

139M

Müük

40M

845M

P/E

Sektori keskmine

42.017

49.052

Aktsiakasum

2.13

Dividenditootlus

0.27

Kasumimarginaal

16.428

Töötajad

10,800

EBITDA

-36M

174M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+13.44% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.27%

2.36%

Järgmine tulemuste avaldamine

23. juuli 2026

Järgmine dividendimakse kuupäev

5. aug 2026

Järgmine aktsia dividendi kuupäev (ex-date)

29. juuli 2026

Turustatistika

By TradingEconomics

Turukapital

2.6B

23B

Eelmine avamishind

328.69

Eelmine sulgemishind

327.95

Uudiste sentiment

By Acuity

50%

50%

146 / 342 Pingereas Healthcare

West Pharmaceutical Services Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Ettevõttest West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat